ALT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Altimmune Inc

Watchlist Manager

Watchlist

Price: 3.3799 USD 4.64% Market Closed

Market Cap: $657.3m

	Altimmune Inc NASDAQ:ALT	US
I	Instituto Rosenbusch SA BCBA:ROSE	AR
	Forte Biosciences Inc NASDAQ:FBRX	US
	Caleffi SpA MIL:CLF	IT
G	Guardian Pharmacy Services Inc NYSE:GRDN	US
A	African Equity Empowerment Investments Ltd JSE:AEE	ZA
C	CITIC Ltd OTC:CTPCF	CN

Profitability Summary

Altimmune Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-323 306%

Negative 3Y Average Operating Margin

-255 898%

Declining Operating Margin

109 513% > -323 306%

Negative Net Margin

-296 000%

Negative 3Y Average Net Margin

-236 995%

Declining Net Margin

101 638% > -296 000%

Negative Free Cash Flow Margin

-246 974%

Negative 3Y Average Free Cash Flow Margin

-198 505%

Declining Free Cash Flow Margin

89 125% > -246 974%

Negative ROE

-29%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1 191%

ROIC is Increasing

-422% > -97%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.